Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Melanoma 6 Carcinoma, Renal Cell 6 Neoplasms 5 Neoplasm Metastasis 3 Esophageal Squamous Cell Carcinoma 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Metastatic Castration-Resistant Prostate Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × GIST × lenvatinib × Clear all

NCT07096609 2026-04-03

LONGIST

Asan Medical Center

Phase 1/2 Recruiting

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡